9 drug(s) with this reaction
4,061 total reports
Somnolence has been reported as an adverse reaction across 9 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 4,061 adverse event reports mention somnolence in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with somnolence, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have somnolence listed in their FDA adverse event reports, sorted by report count:
In addition to somnolence, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
9 drug(s) manufactured by Chattem Inc have somnolence listed in their FDA adverse event reports: LEVOCETIRIZINE DIHYDROCHLORIDE, LIDOCAINE, MENTHOL, FEXOFENADINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE, MENTHOL, and others.
There are a combined 4,061 reports of somnolence across 9 Chattem Inc drug(s) in the FDA adverse event database.